Global Precision Medicine Market, By Products and Services,


New York, June 03, 2021 (GLOBE NEWSWIRE) - Reportlinker.com announces the release of the Global Precision Medicine Market, By Products and Services, By Technology, By Application, By End-User, By Region, Competitive Prediction and Opportunity report, 2026 "- https://www.reportlinker.com/p05916716/?utm_source=GNW

The global precision medicine market was valued at $ 66.85 billion in 2020 and is expected to reach $ 125.67 billion, growing at a CAGR of 10.65% over the forecast period. Precision drugs are patient-specific and vary from individual to individual. Growing populations and rising cancer cases in developing countries like India and China are the main drivers for the growth of the precision medicine market. However, the high price of precision drugs could hamper the growth of the market over the forecast period.

The global precision medicine market is segmented on the basis of products and services, technology, application, end-user, and region. The application segment is further divided into oncology, immunology, cardiology, neurology, respiratory and others.

Of these, oncology had the largest market share in 2020 due to the increasing number of cancer cases worldwide.

In terms of regional analysis, the market is segmented into Asia-Pacific, North America, South America, Middle East and Africa, and Europe. Among these, North America will dominate the global precision medicine market through 2020 due to the increasing adoption of next generation sequencing methods in addition to favorable government policies.

In addition, the Asia-Pacific region is expected to grow at the fastest annual rate due to rising cases of cancer and other deadly diseases in developing countries like India and China.

Major players in the global Precision Medicine market include IBM Watson Group, Roche Holding AG, Thermo Fischer Scientific Inc., Philips Healthcare Ltd., Illumina Inc., Quest Diagnostics Inc., Qiagen NV, AstraZeneca Plc, Agilent Technologies Inc., Novartis AG, NanoString Technologies Inc., NantHealth Inc., Orion Health Inc., Celcuity Inc., InsightRX Inc. and others. The companies pursue various organic and inorganic strategies such as product launches, acquisitions and mergers to strengthen their market position. On April 15, 2021, Agilent Technologies, Inc. completed the acquisition of Resolution Bioscience, a leader in the development and marketing of next-generation sequencing (NGS) -based precision oncology solutions. Resolution Bioscience complements and expands Agilent's capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further meet the demands of the rapidly growing precision medicine market. Additionally, the addition of Resolution Bioscience's liquid biopsy-based diagnostic technologies strengthens Agilent's offerings to biopharmaceutical and clinical diagnostics customers and increases growth opportunities in the company's diagnostics and genomics businesses.

Years considered for this report:

Historic years: 2016-2019
Base year: 2020
Estimated year: 2021
Forecast period: 2022-2026

The aim of the study:

• To analyze the historical growth in market size of the global Precision Medicine Market from FY2016 to FY2020.
• Estimate and forecast the market size of the global Precision Medicine Market from FY2021 to FY2026, and the growth rate to FY2026.
• Classify and forecast the global Precision Medicine market based on products and services, technology, application, end-user, and region.
• Identify drivers and challenges for the global precision medicine market.
• To study competitive developments such as expansions, product launches, mergers and acquisitions, etc. in the global Precision Medicine Market.
• Conducting price analysis for the global precision medicine market.
• Identify and analyze the profile of leading players in the global precision medicine market.
The analyst conducted both primary and extensive desk research for this study. First, the analyst compiled a list of manufacturers around the world.

The analyst then conducted primary research on the identified companies. As part of the interviews, the respondents were also asked about their competitors.

This technique would allow the analyst to include those manufacturers who could not be identified due to the limitations of desk research. The analyst examined the manufacturers, distribution channels and the presence of all major players worldwide.
The analyst calculated the market size of the global Precision Medicine Market using a bottom-up approach that collects data for various end-user segments and forecast for the years to come. The analyst obtained these values ​​from industry experts and company representatives and validated them externally by analyzing historical data of these product types and applications in order to obtain an appropriate overall market size.

The analyst also examined various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports.

Most important target group:

• Precision drug manufacturers, suppliers, distributors and other stakeholders
• Government agencies such as regulators and policy makers
• Organizations, forums and alliances related to precision medicine
• Market research and consulting company
The study is useful in providing answers to several critical questions important to industry stakeholders such as manufacturers, partners, end users, etc., and enables them to plan investments and seize market opportunities.

Report scope:

In this report, the global Precision Medicine Market has been segmented into the following categories in addition to the industry trends listed below:
• Global Precision Medicine Market by Products and Services:
o Precision Medicine Platforms
o Precision medicine tools
o Precision Medical Services
• Global Precision Medicine Market By Technology:
o Big data analysis
the artificial intelligence
o bioinformatics
o Sequencing of the entire genome
o Companion diagnosis
o Next Generation Sequencing (NGS)
o Others
• Global Precision Medicine Market By Application:
o oncology
o immunology
o cardiology
o neurology
o breathing
o Others
• Global Precision Medicine Market By End-User:
o Pharmaceutical and biotechnology companies
o Health IT
o Diagnostic companies
o Clinical research organization
o Research institutes
• Global Precision Medicine Market by Regions:
o North America
United States
Canada
Mexico
o Europe
Germany
United Kingdom
France
Italy
Spain
or Asia Pacific
China
India
Japan
South Korea
Australia
Singapore
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
United Arab Emirates

Competitive landscape

Company Profiles: In-depth analysis of the key companies in the global Precision Medicine Market.

Available adjustments:

With the given market data, we offer adjustments to the specific needs of a company. The following customization options are available for the report:

Company information

• Detailed analysis and profiling of other market participants (up to five)
Read the full report: https://www.reportlinker.com/p05916716/?utm_source=GNW

Via report linker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all the market research you need - instantly and in one place.

__________________________


Global-Precision-Medicine-Market-By-Products-and-Services.gif

https://dailytechnonewsllc.com/global-precision-medicine-market-by-products-and-services/

Comments

Post a Comment

Popular posts from this blog

Singapore aims to curb 'greenwashing' via stress tests, technology: MAS, Banking News & Top Stories

SINGAPORE (BLOOMBERG) - Singapore's financial regulator is turning to regulation and technology to combat so-called "greenwashing," which it believes is the weakest link in expanding sustainable finance. Banks in Singapore will have to undergo stress tests from next year while also making regulatory disclosures to ensure they are managing risks related to climate change and other environmental issues, Ravi Menon, executive director of the Monetary Authority of Singapore, said in an interview. Data validation with technologies that can prove the origin of environmentally friendly products is also needed, he added. Greenwashing is the making of false or misleading claims about the environmental benefits of a product, service, or technology. Mr Menon said the potential for greenwashing is increasing as more funds are allocated to sustainability projects. Stocks and funds that ranked highly on environmental, social, and governance metrics have attracted trillions of dol...
Read more

The Pros and Cons of Lawsuit Loans

The litigation loan industry lends plaintiffs more than $ 100 million each year in the US, but at what cost to the injured and their loved ones? This type of financing is also known as litigation advance, litigation financing, settlement financing, and pre-financing. Regardless of what you call it, the ability to get an advance payment on a pending settlement has helped thousands of people get their costs back during the litigation. That doesn't mean it is risk-free. Litigation loans are typically funded by hedge funds, private investors, or banks willing to lend plaintiffs money with the promise of a high return on their investment. Litigation lending critics have pointed out that the legal standards of other types of lenders inevitably do not apply to this type of lending because it is largely unregulated in most states. The plaintiff lending business emerged over the past decade. This was part of a trend where banks, hedge funds, and private investors put money into other...
Read more

Show Me a Good Loser, and I'll Show You a Good Trader

Hall of Fame soccer coach Vince Lombardi once said, "Show me a good loser and I'll show you a loser." It's an understandable feeling in sport where the effort never to fail, never to lose and never to stop is the key to success. There is no benefit in giving up and admitting that you will lose in a sport like soccer. In other endeavors, it is extremely important to admit that you are in a bad position and you are unlikely to get your way. For example, professional poker players fold a significant number of their hands. It is a smart strategy to take a small loss straight away instead of pressing further when the cards are not in your favor. You may end up with some luck if you stay in, but it's not the wise bet. Better to protect valuable capital and wait for a better opportunity. Poker players who fold are not ashamed to fold. It is an essential strategy if you are going to win. It's only part of the process of professional gambling and it helps imp...
Read more